WallStreetZenWallStreetZen

NASDAQ: ENGN
Engene Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Engene Therapeutics earnings were -$126.9M for the trailing 12 months ending Apr 30, 2026, with N/A growth year over year. The latest ENGN earnings report on Apr 30, 2026 announced Q2 2026 earnings of -$30.2M, up 1.6% from last quarter. For the last reported fiscal year 2025 ending Oct 31, 2025, ENGN reported annual earnings of -$117.3M, with 112.7% growth.

ENGN earnings history

Current Revenue
$0.0
Current Earnings
-$126.9M
Current Profit Margin
0%

ENGN Return on Equity

Current Company
-56.1%
Current Industry
-141.9%
Current Market
13.5%
ENGN's Return on Equity (-56.1%)... subscribe to Premium to read more.
High Return on Equity Performance

ENGN Return on Assets

Current Company
-45.6%
Current Industry
-13.7%
ENGN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ENGN announces earnings.

ENGN Return on Capital Employed

Current Company
-43.39%
Current Industry
-9.6%

ENGN vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ENGN-$122.69M-$126.85MN/A-$2.17
PMN-$40.62M-$40.62MN/A-$17.57
SPRO$15.50M$15.24M-21.67%$0.27
COYA-$21.10M-$21.13MN/A-$1.15
ATHEN/A-$10.35MN/A-$0.60
View Top Biotech Stocks

Engene Therapeutics Earnings Reports & History FAQ

What were Engene Therapeutics's earnings last quarter?

Engene Therapeutics (NASDAQ: ENGN) reported Q1 2026 earnings per share (EPS) of -$0.43, up 15.69% year over year. Total ENGN earnings for the quarter were -$30.23 million. In the same quarter last year, Engene Therapeutics's earnings per share (EPS) was -$0.51.

If you're new to stock investing, here's how to buy Engene Therapeutics stock.

Is Engene Therapeutics profitable or losing money?

As of the last Engene Therapeutics earnings report, Engene Therapeutics is currently losing money. Engene Therapeutics's net profit (also called net income) for the twelve months ending Apr 30, 2026 was -$126.85 million, a 58.8% increase year over year.

What was ENGN's earnings growth in the past year?

As of Engene Therapeutics's earnings date in Q3 2026, Engene Therapeutics's earnings has grown year over year. ENGN earnings in the past year totalled -$126.85 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.